Isolation and Molecular Identification of Bacteriocin-producing Enterococci with Broad Antibacterial Exercise from Conventional Dairy Merchandise in Kerman Province of Iran.
One of many crucial limitations to make use of of bacteriocins produced by lactic acid micro organism as an alternative choice to chemical antibiotics is the slim spectrum of their antibacterial exercise. The goal of current research was isolation and molecular identification of bacteriocin-producing enterococci with broad antibacterial spectrum.
Bacteriocin-producing micro organism had been remoted from native dairies in Kerman. Bacteriocins had been purified by ammonium sulfate methodology and the results of them had been investigated on totally different strains of micro organism.
Additionally, the results of pH and warmth on produced bacteriocins had been investigated. Excessive degree bacteriocin-producing isolates had been recognized based mostly on molecular exams. A complete of 15 strains of bacteriocin-producing Enterococcus had been remoted initially. Enterococcus faecium C-2 and Y-1 strains produced bacteriocins with the very best antibacterial impact. The bacteriocins had been secure in pH ranges from 2 to 12 and their antibacterial exercise was maintained after autoclave remedy.
The utmost bactericidal impact was noticed in opposition to Listeria monocytogenes and Pseudomonas aeruginosa. In conclusion, use of those bacteriocins as an alternative choice to chemical antibiotics is really helpful.
Rat Adenovirus (FL) Positive Control |
|||
| MBS412080-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Rat Adenovirus (K87) Positive Control |
|||
| MBS412081-1mL | MyBiosource | 1mL | EUR 175 |
Rat Adenovirus (K87) Positive Control |
|||
| MBS412081-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Mouse Adenovirus (FL) Positive Control |
|||
| MBS412078-1mL | MyBiosource | 1mL | EUR 175 |
Mouse Adenovirus (FL) Positive Control |
|||
| MBS412078-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Mouse Adenovirus (K87) Positive Control |
|||
| MBS412079-1mL | MyBiosource | 1mL | EUR 175 |
Mouse Adenovirus (K87) Positive Control |
|||
| MBS412079-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Recombinant (E. Coli) Mouse Adenovirus (MADV) Hexon Protein (hxn) Control for Western Blot |
|||
| MADV11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
CMV-Null control Adenovirus, in vivo ready |
|||
| AVP-Null-PBS | GenTarget | 1x1011 IFU/ml x 50ul | EUR 662.4 |
|
Description: Pre-made Null-control Adenovirus, provided in PBS solution. |
|||
Guinea Pig Adenovirus (FL/K87) Positive Control |
|||
| MBS412059-1mL | MyBiosource | 1mL | EUR 175 |
Guinea Pig Adenovirus (FL/K87) Positive Control |
|||
| MBS412059-5x1mL | MyBiosource | 5x1mL | EUR 645 |
Adenovirus Rapid Test Control Pack (2 X 1.5mL) |
|||
| KZMC035 | Zeptometrix | 2 X 1.5mL | EUR 59 |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus B], codon optimized for human cell expression, YP_002213798 |
|||
| VC100290 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus B], codon optimized for human cell expression, YP_002213765 |
|||
| VC100328 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus C], codon optimized for human cell expression, NP_040507 |
|||
| VC100367 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus D], codon optimized for human cell expression, YP_001974422 |
|||
| VC100424 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus E], codon optimized for human cell expression, YP_068018 |
|||
| VC100462 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A [Human adenovirus F], codon optimized for human cell expression, NP_040845 |
|||
| VC100500 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus B], codon optimized for human cell expression, YP_002213799 |
|||
| VC100291 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus B], codon optimized for human cell expression, YP_002213800 |
|||
| VC100292 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus B], codon optimized for human cell expression, YP_002213819 |
|||
| VC100313 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus B], codon optimized for human cell expression, YP_002213826 |
|||
| VC100314 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus B], codon optimized for human cell expression, YP_002213847 |
|||
| VC100323 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus B], codon optimized for human cell expression, YP_002213766 |
|||
| VC100329 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus B], codon optimized for human cell expression, YP_002213767 |
|||
| VC100330 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus B], codon optimized for human cell expression, YP_002213786 |
|||
| VC100350 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus B], codon optimized for human cell expression, YP_002213794 |
|||
| VC100358 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus B], codon optimized for human cell expression, YP_002213836 |
|||
| VC100362 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1A 243R [Human adenovirus C], codon optimized for human cell expression, NP_040508 |
|||
| VC100368 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus C], codon optimized for human cell expression, NP_040510 |
|||
| VC100369 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus C], codon optimized for human cell expression, NP_040511 |
|||
| VC100370 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus C], codon optimized for human cell expression, YP_001551768 |
|||
| VC100390 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus C], codon optimized for human cell expression, NP_597753 |
|||
| VC100396 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus C], codon optimized for human cell expression, NP_597755 |
|||
| VC100400 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus D], codon optimized for human cell expression, YP_001974423 |
|||
| VC100425 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus D], codon optimized for human cell expression, YP_001974446 |
|||
| VC100426 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus D], codon optimized for human cell expression, YP_001974432 |
|||
| VC100446 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus D], codon optimized for human cell expression, YP_001974464 |
|||
| VC100453 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus D], codon optimized for human cell expression, YP_001974470 |
|||
| VC100457 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus E], codon optimized for human cell expression, YP_068019 |
|||
| VC100463 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus E], codon optimized for human cell expression, YP_068020 |
|||
| VC100464 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 125K [Human adenovirus E], codon optimized for human cell expression, YP_068039 |
|||
| VC100483 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus E], codon optimized for human cell expression, YP_068046 |
|||
| VC100490 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus E], codon optimized for human cell expression, YP_068050 |
|||
| VC100494 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 19K [Human adenovirus F], codon optimized for human cell expression, NP_040848 |
|||
| VC100501 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E1B 55K [Human adenovirus F], codon optimized for human cell expression, NP_040850 |
|||
| VC100502 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E3 147K [Human adenovirus F], codon optimized for human cell expression, NP_040873 |
|||
| VC100525 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4 34K [Human adenovirus F], codon optimized for human cell expression, NP_040878 |
|||
| VC100530 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus B], codon optimized for human cell expression, YP_002213848 |
|||
| VC100324 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus B], codon optimized for human cell expression, YP_002213849 |
|||
| VC100325 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus B], codon optimized for human cell expression, YP_002213850 |
|||
| VC100326 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus B], codon optimized for human cell expression, YP_002213851 |
|||
| VC100327 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus B], codon optimized for human cell expression, YP_002213837 |
|||
| VC100363 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus B], codon optimized for human cell expression, YP_002213838 |
|||
| VC100364 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus B], codon optimized for human cell expression, YP_002213839 |
|||
| VC100365 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus B], codon optimized for human cell expression, YP_002213840 |
|||
| VC100366 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus C], codon optimized for human cell expression, YP_001551773 |
|||
| VC100401 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus C], codon optimized for human cell expression, NP_040534 |
|||
| VC100402 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus C], codon optimized for human cell expression, YP_001551774 |
|||
| VC100403 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus C], codon optimized for human cell expression, NP_597756 |
|||
| VC100404 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus D], codon optimized for human cell expression, YP_001974471 |
|||
| VC100458 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus D], codon optimized for human cell expression, YP_001974472 |
|||
| VC100459 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus D], codon optimized for human cell expression, YP_001974473 |
|||
| VC100460 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus D], codon optimized for human cell expression, YP_001974474 |
|||
| VC100461 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus E], codon optimized for human cell expression, YP_068051 |
|||
| VC100495 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus E], codon optimized for human cell expression, YP_068052 |
|||
| VC100496 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus E], codon optimized for human cell expression, YP_068053 |
|||
| VC100497 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf1 [Human adenovirus E], codon optimized for human cell expression, YP_068054 |
|||
| VC100498 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf4 [Human adenovirus F], codon optimized for human cell expression, NP_040879 |
|||
| VC100531 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf3 [Human adenovirus F], codon optimized for human cell expression, NP_040880 |
|||
| VC100532 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf2 [Human adenovirus F], codon optimized for human cell expression, NP_040881 |
|||
| VC100533 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus B], codon optimized for human cell expression, YP_002213846 |
|||
| VC100322 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus B], codon optimized for human cell expression, YP_002213835 |
|||
| VC100361 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus C], codon optimized for human cell expression, YP_001551772 |
|||
| VC100399 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus D], codon optimized for human cell expression, YP_001974469 |
|||
| VC100456 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus E], codon optimized for human cell expression, YP_068049 |
|||
| VC100493 | Origene Technologies GmbH | 10 µg | Ask for price |
Myc-DDK-tagged ORF clone of viral ORF for control protein E4orf6/7 [Human adenovirus F], codon optimized for human cell expression, NP_040877 |
|||
| VC100529 | Origene Technologies GmbH | 10 µg | Ask for price |
Human Anti-Human Adenovirus Hexon Protein (hAd5 hxn) IgG negative control serum |
|||
| 950-110-01N | Alpha Diagnostics | 1 ml | EUR 196.8 |
The Tripod for Bacterial Pure Product Discovery: Genome Mining, Silent Pathway Induction, and Mass Spectrometry-Primarily based Molecular Networking.
Pure merchandise are the richest supply of chemical compounds for drug discovery. Significantly, bacterial secondary metabolites are within the highlight on account of advances in genome sequencing and mining, in addition to for the potential of biosynthetic pathway manipulation to awake silent (cryptic) gene clusters underneath laboratory cultivation.
- Additional progress in compound detection, similar to the event of the tandem mass spectrometry (MS/MS) molecular networking strategy, has contributed to the invention of novel bacterial pure merchandise.
- The latter is usually applied on to bacterial crude extracts for figuring out and dereplicating identified compounds, subsequently aiding the prioritization of extracts containing novel pure merchandise, for instance.
- In our opinion, these three approaches-genome mining, silent pathway induction, and MS-based molecular networking-compose the tripod for contemporary bacterial pure product discovery and will likely be mentioned on this perspective.
Pharmacophore and molecular dynamics based mostly exercise profiling of pure merchandise for kinases concerned in lung most cancers.
To find out the kinase inhibitory potential of pure merchandise that may very well be utilized in lung most cancers remedy within the close to future, a pharmacophore-based exercise profiling protocol utilizing parallel pharmacophore-based digital screening of ZINC-a pure product database-was employed.
The work offered right here relies on the beforehand explored undeniable fact that pharmacophore-based parallel screening is a dependable in silico protocol to foretell the attainable organic actions of any compound, or any compound library, by screening it with numerous pharmacophore fashions.
The current research entails ligand-based pharmacophore modeling of varied kinases, together with EGFR (T790 M), cMET, ErbB2, FGFR and ALK, that are properly established targets of regular as properly resistant lung most cancers. The generated pharmacophore fashions had been then utilized for parallel and cross screening. The profiled molecules for every goal had been then validated utilizing molecular docking and molecular dynamic simulations.
The outcomes present that kinase inhibitory exercise profiling of some pure product molecules was efficiently achieved. Graphical summary Pharmacophore and exercise profiling of pure merchandise for kinases concerned in lung cance
Utility of the fragment molecular orbital methodology to find novel pure merchandise for prion illness.
Conformational conversion of the conventional mobile isoform of the prion protein PrPC into an infectious isoform PrPSc causes pathogenesis in prion illnesses.
So far, quite a few antiprion compounds have been developed to dam this conversion and to detect the molecular mechanisms of prion inhibition utilizing a number of computational research.
So far, no appropriate drug has been recognized for medical use. For these causes, extra correct and predictive approaches to establish novel compounds with antiprion results are required. Right here, we’ve utilized an in silico strategy that integrates our beforehand described pharmacophore mannequin and fragment molecular orbital (FMO) calculations, enabling the ab initio calculation of protein-ligand complexes.
The FMO-based digital screening urged that two pure merchandise with antiprion activity exhibited good binding interactions, with hotspot residues throughout the PrPC binding web site, and successfully diminished PrPSc ranges in an ordinary scrapie cell assay. General, the end result of this research will likely be used as a promising technique to find antiprion compounds.
Moreover, the SAR-by-FMO strategy can present extraordinarily highly effective instruments in shortly establishing digital SAR to prioritise compounds for synthesis in additional research
25 mm Diameter Solid Titanium Tip |
|||
| 0-120-0015 | Biologics | 25 mm | EUR 614 |
Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|||
| 0-120-0016 | Biologics | 13 mm | EUR 86 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|||
| 0-120-0017 | Biologics | 19 mm | EUR 92 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
| 0-120-0018 | Biologics | 25 mm | EUR 100 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Titanium Cup Tip, 250 ml |
|||
| 0-120-0019 | Biologics | 250 ml | EUR 1377 |
|
Description: includes Interface Washers |
|||
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
| 0-120-0021 | Biologics | each | EUR 113 |
|
Description: includes Interface Washers |
|||
Continuous Flow Chamber |
|||
| 0-120-0026 | Biologics | each | EUR 774 |
|
Description: includes Interface Washers |
|||
Interface Washers 1.5” Diameter, 5/Pkg |
|||
| 0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
| 0-120-0038 | Biologics | 1.5 ml | EUR 152 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 15ml Conical Tube |
|||
| 0-120-0039 | Biologics | 15 ml | EUR 275 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 50ml Conical Tube |
|||
| 0-120-0040 | Biologics | 50 ml | EUR 290 |
|
Description: Thermo conductive tube pods |
|||
Model 150 V/T Ultrasonic Homogenizer |
|||
| 0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
|||
Model 300 V/T Ultrasonic Homogenizer |
|||
| 0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
|||
SONABOZ Sound Abating Chamber |
|||
| 0-125-0001 | Biologics | each | EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
|||
Model 3000 Ultrasonic Homogenizer |
|||
| 0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
|||
Model 3000MP Ultrasonic Homogenizer |
|||
| 0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
|||
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
| 0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
|||
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
| 0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
|||
Peni Cylinder Dispenser with Manual Hopper |
|||
| 0-144-0002 | Biologics | each | EUR 5406 |
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
|||
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
| 0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
|||
Stainless Steel Peni Cylinder with Flat Face |
|||
| 0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
|
Description: sold in packages of 100 pieces |
|||
Stainless Steel Peni Cylinder with Chamfered Face |
|||
| 0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
|
Description: sold in packages of 100 pieces |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
| 000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002 | Biotium | 1UG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-bungarotoxin, CF405s |
|||
| 00002 | Cusabio | 500uG | EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
| 00002-100ug | Biotium | 100uG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
| 0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1 | Biotium | 1MG | EUR 193 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011 | Biotium | 500uG | EUR 376 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012 | Biotium | 500uG | EUR 394 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013 | Biotium | 10ST | EUR 436 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014 | Biotium | 10ST | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015 | Biotium | 500uG | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016 | Biotium | 10ST | EUR 560 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017 | Biotium | 500uG | EUR 455 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
|
Description: 79-06-1 |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
|
Description: 79-06-1 |
|||
Biotin-cAMP, 1 mg |
|||
| 00020 | Biotium | 1MG | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 1 mg |
|||
| 00020-1 | Biotium | 20ST | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 50 ug |
|||
| 00020-1-1 | Biotium | EA | EUR 414 |